Seyed Mojtaba Sohrevardi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Seyed Mojtaba Sohrevardi has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Golnaz Afzal
Department of Clinical Pharmacy, School of Pharmacy, Shahid Sadoughi University of Medical Science, Yazd, Iran
2 shared publications - Abbas Pardakhty
Pharmaceutics Research Center, Institute of Pharmaceutical Sciences, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication - Ali Dehshahri
Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
1 shared publication - Ali Mandegary
Department of Toxicology and Pharmacology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication - Arezoo Dadashzadeh
Pôle de Recherche en Physiopathologie de la Reproduction, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium
1 shared publication Farhad Sarrafzadeh
Neuroscience Research Center and Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication
Latest Publications
- Open Access
- 27 February 2025
- Published by Springer Nature in BMC Geriatrics
- Vol. 25 (1) , 1-11
Drug prescription patterns and compliance with WHO and beers criteria in older patients
As the population ages, the prevalence of chronic diseases increases, leading to greater reliance on multiple medications that are conducted to increase the risk of adverse drug reactions (ADR) that may cause higher morbidity and mortality rates. This study aims to evaluate medication prescribing patterns in the older adults and assess compliance with the World Health Organization (WHO) guidelines and Beers Criteria. A cross-sectional study was conducted over six months in 2022, collecting prescriptions for patients aged 65 and above from a 24-hour community pharmacy in Iran. The prescriptions were analyzed according to the WHO prescribing guidelines, including the mean number of prescribed drugs, the number of injectable drugs and antibiotics per prescription, and also the prescription of drugs with generic names and from the list of Essential Drug List (EDL). In addition, the prescriptions were assessed according to the Beers Criteria for the frequency of prescription of potentially inappropriate medications (PIMs). Also, polypharmacy, which is defined as the prescription of more than five drugs per prescription, has been investigated based on the number of drugs prescribed per prescription. 1,053 older patient prescriptions were assessed, whose average age was 72.3 ± 6.7 years, with 36.2% of prescriptions involving polypharmacy (five or more drugs). The most frequent medical discipline of prescribers was general practice (30.3%). The average number of drugs per prescription was 4.1 ± 2.1, which exceeded the WHO recommendation. Additionally, 47.3% of prescriptions contained at least one PIM according to the Beers Criteria, with non-steroidal anti-inflammatory drugs (NSAIDs) being the most common (17.9%). The relative frequency of injectable drugs and antibiotics used per prescription was 20.8 and 18.9%, respectively, while 7.6% of prescriptions did not use generic names. The study highlights concern about levels of polypharmacy and PIM use in older patients. While the low rate of antibiotic prescribing and relatively high use of generic drugs indicate some positive adherence to WHO guidelines, the frequent prescription of PIMs and the high average number of drugs per prescription point to substantial room for improvement.
- 27 February 2025
- Published by Springer Nature in BMC Geriatrics
- Vol. 25 (1) , 1-11
Open AccessDrug prescription patterns and compliance with WHO and beers criteria in older patients
As the population ages, the prevalence of chronic diseases increases, leading to greater reliance on multiple medications that are conducted to increase the risk of adverse drug reactions (ADR) that may cause higher morbidity and mortality rates. This study aims to evaluate medication prescribing patterns in the older adults and assess compliance with the World Health Organization (WHO) guidelines and Beers Criteria. A cross-sectional study was conducted over six months in 2022, collecting prescriptions for patients aged 65 and above from a 24-hour community pharmacy in Iran. The prescriptions were analyzed according to the WHO prescribing guidelines, including the mean number of prescribed drugs, the number of injectable drugs and antibiotics per prescription, and also the prescription of drugs with generic names and from the list of Essential Drug List (EDL). In addition, the prescriptions were assessed according to the Beers Criteria for the frequency of prescription of potentially inappropriate medications (PIMs). Also, polypharmacy, which is defined as the prescription of more than five drugs per prescription, has been investigated based on the number of drugs prescribed per prescription. 1,053 older patient prescriptions were assessed, whose average age was 72.3 ± 6.7 years, with 36.2% of prescriptions involving polypharmacy (five or more drugs). The most frequent medical discipline of prescribers was general practice (30.3%). The average number of drugs per prescription was 4.1 ± 2.1, which exceeded the WHO recommendation. Additionally, 47.3% of prescriptions contained at least one PIM according to the Beers Criteria, with non-steroidal anti-inflammatory drugs (NSAIDs) being the most common (17.9%). The relative frequency of injectable drugs and antibiotics used per prescription was 20.8 and 18.9%, respectively, while 7.6% of prescriptions did not use generic names. The study highlights concern about levels of polypharmacy and PIM use in older patients. While the low rate of antibiotic prescribing and relatively high use of generic drugs indicate some positive adherence to WHO guidelines, the frequent prescription of PIMs and the high average number of drugs per prescription point to substantial room for improvement.
- Open Access
- 27 November 2023
- Published by Knowledge E DMCC in Journal of Shahid Sadoughi University of Medical Sciences
Evaluation of Rational Use of Linezolid in Hospitalized Patient in Shahid Chamran Hospital in Isfahan City during the Second Six Months of the 2021
Introduction: The rational use of drugs is one of the main elements of achieving the best pharmacotherapy method for patients. Linezolid is used for infections caused by gram-positive bacteria, including vancomycin-resistant staphylococci and vancomycin-resistant enterococci, but the inappropriate use of this drug has led to the emergence of linezolid-resistant strains. The purpose of this study was to investigate the manner of Linezolid prescription in Shahid Chamran Hospital of Isfahan City in 2021. Methods: This cross sectional study was conducted during a period of 6 months (From September 1, 2021 to February 31, 2022) on 102 patients admitted to Shahid Chamran Hospital in Isfahan City. Patient information such as demographic information, indication and dosages of drugs, the basis of drug prescription, side effects and drug interactions, etc. were extracted from the medical records of patients and hospital systems and recorded in designed forms. After matching the information with the relevant guidelines, statistical analysis was performed using SPSS-16 software. Results: Out of the 102 patients, who received linezolid, 75.1% were men and the rest were women. 99% of the cases were prescribed experimentally and 1% was based on culture. In 40.2% of the patients, drugs were prescribed irrationally in terms of prescription indications. In 84.3% of the cases, a change in treatment regimen was observed after receiving the culture results. Conclusion: A large percentage of cases of linezolid drug prescription was not done correctly. Furthermore, it has not been attention to the side effects caused by the drug, especially thrombocytopenia.
- 27 November 2023
- Published by Knowledge E DMCC in Journal of Shahid Sadoughi University of Medical Sciences
Open AccessEvaluation of Rational Use of Linezolid in Hospitalized Patient in Shahid Chamran Hospital in Isfahan City during the Second Six Months of the 2021
Introduction: The rational use of drugs is one of the main elements of achieving the best pharmacotherapy method for patients. Linezolid is used for infections caused by gram-positive bacteria, including vancomycin-resistant staphylococci and vancomycin-resistant enterococci, but the inappropriate use of this drug has led to the emergence of linezolid-resistant strains. The purpose of this study was to investigate the manner of Linezolid prescription in Shahid Chamran Hospital of Isfahan City in 2021. Methods: This cross sectional study was conducted during a period of 6 months (From September 1, 2021 to February 31, 2022) on 102 patients admitted to Shahid Chamran Hospital in Isfahan City. Patient information such as demographic information, indication and dosages of drugs, the basis of drug prescription, side effects and drug interactions, etc. were extracted from the medical records of patients and hospital systems and recorded in designed forms. After matching the information with the relevant guidelines, statistical analysis was performed using SPSS-16 software. Results: Out of the 102 patients, who received linezolid, 75.1% were men and the rest were women. 99% of the cases were prescribed experimentally and 1% was based on culture. In 40.2% of the patients, drugs were prescribed irrationally in terms of prescription indications. In 84.3% of the cases, a change in treatment regimen was observed after receiving the culture results. Conclusion: A large percentage of cases of linezolid drug prescription was not done correctly. Furthermore, it has not been attention to the side effects caused by the drug, especially thrombocytopenia.
- Open Access
- 15 August 2021
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 64 (8) , 415-421
Prevalence of methicillin-resistant Staphylococcus aureus in Iranian children: a systematic review and meta-analysis
Background: Antibiotic resistance is associated with longer hospitalizations, higher treatment costs, and increased morbidity and mortality rates.Purpose: This study aimed to determine the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in Iranian children.Methods: International databases, including Web of Science, PubMed, Embase, and Scopus, and Iranian databases, including Scientific Information Database (www.sid.ir), Magiran, and Iranian Database for Medical Literature (idml.research.ac.ir), were systematically searched for articles published between January 2000 and August 2019. Sources of heterogeneity were determined using subgroup analysis and meta-regression.Results: Overall, 343 studies were identified; of them, 20 were included in the meta-analysis to estimate the pooled prevalence. The pooled prevalence of MRSA was 42% (95% confidence interval [CI], 29–55) among culture-positive cases of S. aureus, 51% (95% CI, 39–62) in hospitalized children, and 14% (95% CI, 0.05–27) in healthy children.Conclusion: The overall pooled prevalence of MRSA in children was 42%. Appropriate infection control measures and effective antibiotic therapy are needed.
- 15 August 2021
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 64 (8) , 415-421
Open AccessPrevalence of methicillin-resistant Staphylococcus aureus in Iranian children: a systematic review and meta-analysis
Background: Antibiotic resistance is associated with longer hospitalizations, higher treatment costs, and increased morbidity and mortality rates.Purpose: This study aimed to determine the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in Iranian children.Methods: International databases, including Web of Science, PubMed, Embase, and Scopus, and Iranian databases, including Scientific Information Database (www.sid.ir), Magiran, and Iranian Database for Medical Literature (idml.research.ac.ir), were systematically searched for articles published between January 2000 and August 2019. Sources of heterogeneity were determined using subgroup analysis and meta-regression.Results: Overall, 343 studies were identified; of them, 20 were included in the meta-analysis to estimate the pooled prevalence. The pooled prevalence of MRSA was 42% (95% confidence interval [CI], 29–55) among culture-positive cases of S. aureus, 51% (95% CI, 39–62) in hospitalized children, and 14% (95% CI, 0.05–27) in healthy children.Conclusion: The overall pooled prevalence of MRSA in children was 42%. Appropriate infection control measures and effective antibiotic therapy are needed.
- Open Access
- 1 July 2019
- Published by Elsevier in Journal of Advanced Research
- Vol. 18, 81-93
Shedding light on gene therapy: Carbon dots for the minimally invasive image-guided delivery of plasmids and noncoding RNAs - A review
- 1 July 2019
- Published by Elsevier in Journal of Advanced Research
- Vol. 18, 81-93
Open AccessShedding light on gene therapy: Carbon dots for the minimally invasive image-guided delivery of plasmids and noncoding RNAs - A review
- Open Access
- 1 January 2013
- Vol. 12 (1) , 211-6
Evaluation of Bactereuria and Antimicrobial Susceptibility among Hospitalized Patients With and Without Catheter in Kerman Province- Iran in 2011.
Nearly 15% to 25% of patients in general hospitals have a catheter at some time during their stay. Up to 97% of nosocomial urinary tract infections (UTIs) are related to catheter. The type of bacteremia is usually polymicrobial which makes the treatment more difficult. Previous studies showed an increase in mortality from bacteremia in these patients. The aim of the present study was to compare the prevalence of UTIs among patients with and without catheter, and to detect the type of bacteriuria and antibacterial resistance pattern. In this cross sectional study, samples were taken between Jan 2011 and July 2011. 678 hospitalized patients in different wards of Afzalipour hospital, Kerman- Iran, were enrolled in the study. E-test was applied to detect the pattern of resistance to gentamicin, nitrofurantoin, ciprofloxacin, ceftriaxon and co-trimoxazole. Results showed positive culture samples in 86% of female patients. Escherichia coli, Candida and Staphylococcus aureus were detected in 72, 20 and 7 percent of the positive cultures, respectively. 52.3% of detected E.coli was sensitive to gentamicin , 62% to ceftriaxone, 71.4% to ciprofloxacin, and 91.9% were sensitive to nitrofurantoin. Therefore, the most sensitive antibiotics in UTIs were ciprofloxacin and ceftriaxone. Unfortunately, the rate of antibacterial drug resistance was high in comparison with developed countries. Wise selection of antibiotics at hospitals and increasing the knowledge of patients to prevent self use of antibiotics can reduce antimicrobial resistance.
- 1 January 2013
- Vol. 12 (1) , 211-6
Open AccessEvaluation of Bactereuria and Antimicrobial Susceptibility among Hospitalized Patients With and Without Catheter in Kerman Province- Iran in 2011.
Nearly 15% to 25% of patients in general hospitals have a catheter at some time during their stay. Up to 97% of nosocomial urinary tract infections (UTIs) are related to catheter. The type of bacteremia is usually polymicrobial which makes the treatment more difficult. Previous studies showed an increase in mortality from bacteremia in these patients. The aim of the present study was to compare the prevalence of UTIs among patients with and without catheter, and to detect the type of bacteriuria and antibacterial resistance pattern. In this cross sectional study, samples were taken between Jan 2011 and July 2011. 678 hospitalized patients in different wards of Afzalipour hospital, Kerman- Iran, were enrolled in the study. E-test was applied to detect the pattern of resistance to gentamicin, nitrofurantoin, ciprofloxacin, ceftriaxon and co-trimoxazole. Results showed positive culture samples in 86% of female patients. Escherichia coli, Candida and Staphylococcus aureus were detected in 72, 20 and 7 percent of the positive cultures, respectively. 52.3% of detected E.coli was sensitive to gentamicin , 62% to ceftriaxone, 71.4% to ciprofloxacin, and 91.9% were sensitive to nitrofurantoin. Therefore, the most sensitive antibiotics in UTIs were ciprofloxacin and ceftriaxone. Unfortunately, the rate of antibacterial drug resistance was high in comparison with developed countries. Wise selection of antibiotics at hospitals and increasing the knowledge of patients to prevent self use of antibiotics can reduce antimicrobial resistance.